2009
DOI: 10.1016/j.mehy.2008.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Is dysfunction of the tissue plasminogen activator (tPA)-plasmin pathway a link between major depression and cardiovascular disease?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
14
0
2

Year Published

2009
2009
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 38 publications
0
14
0
2
Order By: Relevance
“…An association between BDNF and depression has been demonstrated in clinical and animal studies. Animal and human studies have revealed that BDNF may play an important role in the pathogenesis of depression and, therefore, might be involved in the therapeutic effects of antidepressants (59). Animal experiments have demonstrated that decreases in BDNF were associated with depressive states, and clinical studies have shown that administration of BDNF can reverse these states (60).…”
Section: Discussionmentioning
confidence: 99%
“…An association between BDNF and depression has been demonstrated in clinical and animal studies. Animal and human studies have revealed that BDNF may play an important role in the pathogenesis of depression and, therefore, might be involved in the therapeutic effects of antidepressants (59). Animal experiments have demonstrated that decreases in BDNF were associated with depressive states, and clinical studies have shown that administration of BDNF can reverse these states (60).…”
Section: Discussionmentioning
confidence: 99%
“…131 tPA is a thrombolytic enzyme, with neuroplastic and apoptotic functions in the brain. 132 Its expression is upregulated in stress, 133 and low levels of tPA have been found in depressed patients.…”
Section: Discussionmentioning
confidence: 99%
“…55 Recently, it has been hypothesized that variations of tissue-type plasminogen activator (tPA) and its inhibitor plasminogen activator inhibitor-1 (PAI-1), both widely expressed in the brain, might be related to stress reaction and depression and thus provide a further plausible link between major depressive disorders and CVD. 56 Previous epidemiologic investigations have shown that both male and female patients with mental depression have higher PAI-1 levels than those of healthy controls. 57,58 Moreover, in the brain, t-PA has been implicated in the cleavage of proBDNF (brainderived neurotrophic factor) to BDNF, a peptide whose role in the pathogenesis of mental depression is now well established.…”
Section: Hypercoagulable Statementioning
confidence: 98%
“…Additional to the role of fibrinolysis in the pathogenesis of mental depression, the above might also reflect therapeutic potential, as targeting of the fibrinolytic system, namely the t-PA/PAI-1 pathway, with specific drugs could ease the treatment of patients with both CVD and mental depression. 56 Platelet Activation Increased platelet reactivity has been suggested as a mechanism by which depression increases adverse cardiovascular events in CAD patients. 61 Both baseline platelet activation and responsiveness might be increased in depressed patients.…”
Section: Hypercoagulable Statementioning
confidence: 99%